Journals / Marmara Medical Journal / 2019 / Cilt: 32 - Sayı: 1

Investigation of the effectiveness of algan hemostatic agent in bleeding control using an experimental partial splenectomy model in rats

Deneysel parsiyel splenektomi modelinde sıçanlarda algan hemostatik ajanın kanama kontrolünde etkinliğinin araştırılması

Pages
27–32
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Objective: Algan hemostatic agent (AHA) is a plant-based

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Algan hemostatic agent (AHA) is a plant-based
📊
Key Findings & Data:Objective: Algan hemostatic agent (AHA) is a plant-based
💡
Conclusion & Impact:Objective: Algan hemostatic agent (AHA) is a plant-based
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Algan hemostatik ajan · Hemostaz · Sıçan

Abstract

Objective: Algan hemostatic agent (AHA) is a plant-based

Özet

Amaç: Algan hemostatik ajan (AHA), Türkiye’de üretilen bitki

🔖

Cite This Article

MİDİ, A., EKİCİ, H., KUMANDAŞ, A., DURMUŞ, Ö., BODİÇ, B., TİRYAKİ, M. Z., BALIK, M. S., YEŞİLADA, E. (2019). Investigation of the effectiveness of algan hemostatic agent in bleeding control using an experimental partial splenectomy model in rats. Marmara Medical Journal, Cilt: 32 - Sayı: 1, 27–32. https://ajindex.com/articles/283803

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (8)

  1. Uranus S, Mischinger HJ, Pfeifer J, et al. Hemostatic methods for the management of spleen and liver injuries. World J Surg 1996;20:1107-11. doi: 10.1007/s002689900
  2. Davies DA, Pearl RH, Ein SH, Langer JC, Wales PW. Management of blunt splenic injury in children: Evolution of the nonoperative approach. J Pediatr Surg 2009;44:1005-8. doi: 10.1016/j.jpedsurg.2009.01.024
  3. Kuzu A, Aydıntuğ S, Karayalçın K, Köksoy C, Yerdel M A, Eraslan S. Use of autologous fibrin glue in the treatment of splenic trauma: an experimental study. Journal of Royal College of Surgeons Edinburgh 1992;37:162-4
  4. King H, Shumacker HB Jr. Splenic studies: Susceptibility to infection after splenectomy performed in\wiancy. Ann Surg 1952;136: 239-42
  5. Schwartz M, Madariaga J, Hirose R, et al. Comparison of a new fibrin sealant with standard topical hemostatic agents. Arch Surg 2004;139:1148-54. doi:10.1001/ archsurg.139.11.1148 6. Hanks JB, Kjaergaard HK, Hollingsbee DA. A comparison of the haemostatic effect of Vivostat patient-derived fibrin sealant with oxidised cellulose (Surgicel) in multiple surgical procedures. Eur Surg Res 2003;35:439-44. doi: 10.1159/000072229 7. Ersoy G, Kaynak MF, Yilmaz O, Rodoplu U, Maltepe F, Gokmen N. Hemostatic effects of microporous polysaccharide hemosphere in a rat model with severe femoral artery bleeding. Adv Ther 2007;24:485-92. doi: 10.1007/BF02848770
  6. Ward KR, Tiba MH, Holbert WH, et al. Comparison of a new hemostatic agent to current combat hemostatic agents in a swine model of lethal extremity arterial hemorrhage. J Trauma 2007;63:276-83. doi: 10.1097/TA.0b013e3180eea8a5 9. Beyazit Y, Kurt M, Kekilli M, Goker H, Haznedaroglu IC. Evaluation of hemostatic effects of Ankaferd as an alternative medicine. Altern Med Rev 2010;15:329-36
  7. Uçar Albayrak C, Caliskan U, Haznedaroglu IC, Goker H. Haemostatic actions of the folkloric medicinal plant extract Ankaferd Blood Stopper. J Int Med Res 2008;36:1447-8.doi: 10.1177/147.323.000803600121
  8. Köse R, Sogut Ö, Demir T, Koruk İ. Hemostatic efficacy of folkloric medicinal plant extract in a rat skin bleeding model. Dermatol Surg 2012;38, 760-6. doi: 10.1111/j.1524- 4725.2011.02288.x 12. Yavuz E, Kalayci M U, Kesici S, Kesici U, Ozkara S, Yalcin O. Efficacy of ankaferd blood stopper in bleeding control in experimental partial splenectomy model. Kafkas Universitesi Veteriner Fakultesi Dergisi 2012;18: 753-8. doi:10.9775/ kvfd.2012.6324 13. Midi A, Kumandaş A, Ekici H, et al. Investigation o